Finance

Lists
ONESOURCE:NSE
Onesource Specialty Pharma Ltd
₹1,500.00
-1.42%
(-21.60) 1D
Oct 1, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ONESOURCE...
Open
₹1,516.00
High
₹1,542.20
Low
₹1,433.60
Mkt. cap
172.01B
Avg. vol.
299.14K
Volume
608.71K
52-wk high
₹1,925.00
52-wk low
₹1,057.00
EPS
-₹4.25
No. of employees
2K
Open
₹1,516.00
High
₹1,542.20
Low
₹1,433.60
Mkt. cap
172.01B
Avg. vol.
299.14K
Volume
608.71K
52-wk high
₹1,925.00
52-wk low
₹1,057.00
EPS
-₹4.25
No. of employees
2K
News stories
From web sources and news partners
About Onesource Specialty Pharma Ltd
CEO-
Employees1.67K
Founded2007
Headquarters-
SectorHealth care
Websiteonesourcecdmo.com
Last report
Jul 25, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
₹2.56 / ₹5.30
-51.79%miss
Revenue / Est. (INR)
4.49B / 4.96B
-9.39%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.76B
2.90B
4.30B
4.49B
Cost of goods sold
1.13B
943.66M
2.35B
1.42B
Cost of revenue
1.13B
943.66M
2.35B
1.42B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
628.21M
641.92M
749.51M
686.80M
Operating expense
2.26B
2.48B
2.04B
2.55B
Total operating expenses
3.39B
3.43B
4.39B
3.97B
Operating income
366.68M
-523.15M
-87.15M
516.01M
Other non operating income
30.36M
46.25M
-229.61M
38.02M
EBT including unusual items
57.41M
-930.11M
-2.92M
202.94M
EBT excluding unusual items
57.41M
-859.21M
-4.48M
245.94M
Income tax expense
-47.44M
-43.12M
-48.89M
-47.03M
Effective tax rate
-82.63%
4.64%
1,674.32%
-23.17%
Other operating expenses
929.57M
1.14B
572.91M
1.15B
Net income
104.85M
-886.99M
45.97M
249.97M
Net profit margin
2.79%
-30.55%
1.07%
5.57%
Earnings per share
-
-7.15
-
2.56
Interest and investment income
-
-
115.54M
-
Interest expense
-339.63M
-382.31M
-117.67M
-308.09M
Net interest expenses
-339.63M
-382.31M
-2.13M
-308.09M
Depreciation and amortization charges
698.27M
696.37M
718.26M
717.46M
EBITDA
1.05B
92.24M
540.71M
1.21B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps